PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.75%
Positive revenue growth while 3391.T is negative. John Neff might see a notable competitive edge here.
10.29%
Positive gross profit growth while 3391.T is negative. John Neff would see a clear operational edge over the competitor.
11.03%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
42.26%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
26.24%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
26.24%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
26.24%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Share reduction more than 1.5x 3391.T's 0.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.65%
10Y revenue/share CAGR under 50% of 3391.T's 72.76%. Michael Burry would suspect a lasting competitive disadvantage.
-2.00%
Negative 5Y CAGR while 3391.T stands at 63.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.84%
Negative 3Y CAGR while 3391.T stands at 39.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
51.37%
Below 50% of 3391.T's 178.42%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
22.70%
Below 50% of 3391.T's 284.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-13.67%
Negative 3Y CAGR while 3391.T is 13.90%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
62.70%
10Y equity/share CAGR at 50-75% of 3391.T's 95.83%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
33.26%
Below 50% of 3391.T's 80.46%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-10.59%
Negative 3Y equity/share growth while 3391.T is at 47.89%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-45.83%
Cut dividends over 10 years while 3391.T stands at 56311.12%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
41.30%
Below 50% of 3391.T's 68621.26%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-26.14%
Negative near-term dividend growth while 3391.T invests at 68.80%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
25094.44%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.93%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.97%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.74%
BV/share growth above 1.5x 3391.T's 3.70%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
54.19%
Debt growth far above 3391.T's 0.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-41.59%
We cut SG&A while 3391.T invests at 6.52%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.